NASDAQ:HCAT Health Catalyst (HCAT) Stock Price, News & Analysis $4.19 +0.20 (+5.01%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$4.20 +0.00 (+0.12%) As of 05/2/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Health Catalyst Stock (NASDAQ:HCAT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Health Catalyst alerts:Sign Up Key Stats Today's Range$4.03▼$4.2450-Day Range$3.58▼$4.9452-Week Range$3.56▼$9.24Volume520,454 shsAverage Volume607,232 shsMarket Capitalization$294.18 millionP/E RatioN/ADividend YieldN/APrice Target$8.05Consensus RatingModerate Buy Company OverviewHealth Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.Read More… Health Catalyst Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks90th Percentile Overall ScoreHCAT MarketRank™: Health Catalyst scored higher than 90% of companies evaluated by MarketBeat, and ranked 80th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingHealth Catalyst has received a consensus rating of Moderate Buy. The company's average rating score is 2.70, and is based on 7 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageHealth Catalyst has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Health Catalyst's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Health Catalyst are expected to grow in the coming year, from ($0.33) to ($0.29) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Health Catalyst is -3.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Health Catalyst is -3.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHealth Catalyst has a P/B Ratio of 0.66. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Health Catalyst's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.33% of the float of Health Catalyst has been sold short.Short Interest Ratio / Days to CoverHealth Catalyst has a short interest ratio ("days to cover") of 4.2.Change versus previous monthShort interest in Health Catalyst has recently increased by 1.28%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHealth Catalyst does not currently pay a dividend.Dividend GrowthHealth Catalyst does not have a long track record of dividend growth. Sustainability and ESG3.8 / 5Environmental Score-0.91 Percentage of Shares Shorted5.33% of the float of Health Catalyst has been sold short.Short Interest Ratio / Days to CoverHealth Catalyst has a short interest ratio ("days to cover") of 4.2.Change versus previous monthShort interest in Health Catalyst has recently increased by 1.28%, indicating that investor sentiment is decreasing. News and Social Media3.1 / 5News Sentiment0.53 News SentimentHealth Catalyst has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Health Catalyst this week, compared to 4 articles on an average week.Search Interest1 people have searched for HCAT on MarketBeat in the last 30 days. MarketBeat Follows2 people have added Health Catalyst to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Health Catalyst insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $225,906.00 in company stock.Percentage Held by InsidersOnly 2.50% of the stock of Health Catalyst is held by insiders.Percentage Held by Institutions85.00% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Health Catalyst's insider trading history. Receive HCAT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter. Email Address HCAT Stock News HeadlinesHealth Catalyst Announces Strategic Partnership with Microsoft to Accelerate AI Adoption and Transformation for Care Delivery OrganizationsApril 29, 2025 | prnewswire.comCitigroup Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $6.50April 28, 2025 | americanbankingnews.comTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.May 4, 2025 | Porter & Company (Ad)Brokerages Set Health Catalyst, Inc. (NASDAQ:HCAT) Target Price at $8.36April 27, 2025 | americanbankingnews.comHealth Catalyst price target lowered to $6.50 from $7 at CitiApril 26, 2025 | markets.businessinsider.comQ4 Earnings Outperformers: Health Catalyst (NASDAQ:HCAT) And The Rest Of The Data Analytics StocksApril 25, 2025 | msn.comHealth Catalyst price target lowered to $5 from $7 at KeyBancApril 17, 2025 | markets.businessinsider.comHealth Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025April 17, 2025 | globenewswire.comSee More Headlines HCAT Stock Analysis - Frequently Asked Questions How have HCAT shares performed this year? Health Catalyst's stock was trading at $7.07 at the beginning of 2025. Since then, HCAT stock has decreased by 40.7% and is now trading at $4.19. View the best growth stocks for 2025 here. How were Health Catalyst's earnings last quarter? Health Catalyst, Inc. (NASDAQ:HCAT) issued its earnings results on Wednesday, November, 6th. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.10 by $0.03. The business's revenue for the quarter was up 3.5% compared to the same quarter last year. Read the conference call transcript. When did Health Catalyst IPO? Health Catalyst (HCAT) raised $129 million in an initial public offering on Thursday, July 25th 2019. The company issued 6,000,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair acted as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers. Who are Health Catalyst's major shareholders? Health Catalyst's top institutional investors include Nepsis Inc. (2.98%), Massachusetts Financial Services Co. MA (0.44%), Bank of New York Mellon Corp (0.28%) and SG Americas Securities LLC (0.12%). Insiders that own company stock include Daniel D Burton, Bryan Truman Hunt, Kevin Lee Freeman, Daniel Lesueur, Benjamin Landry, Daniel H Orenstein, Jason Alger, Linda Llewelyn and Duncan Gallagher. View institutional ownership trends. How do I buy shares of Health Catalyst? Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Health Catalyst own? Based on aggregate information from My MarketBeat watchlists, some other companies that Health Catalyst investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY), Voyager Therapeutics (VYGR) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings11/06/2024Today5/04/2025Next Earnings (Estimated)5/07/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Computer programming, data processing, & other computer related Sub-IndustryComputer Software Current SymbolNASDAQ:HCAT CIK1636422 Webwww.healthcatalyst.com Phone(801) 708-6800FaxN/AEmployees1,200Year FoundedN/APrice Target and Rating Average Stock Price Target$8.05 High Stock Price Target$16.00 Low Stock Price Target$4.00 Potential Upside/Downside+92.0%Consensus RatingModerate Buy Rating Score (0-4)2.70 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)($1.15) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-118,150,000.00 Net Margins-26.20% Pretax Margin-26.25% Return on Equity-7.51% Return on Assets-3.72% Debt Debt-to-Equity Ratio0.32 Current Ratio1.41 Quick Ratio1.41 Sales & Book Value Annual Sales$306.58 million Price / Sales0.96 Cash FlowN/A Price / Cash FlowN/A Book Value$6.38 per share Price / Book0.66Miscellaneous Outstanding Shares70,211,000Free Float59,327,000Market Cap$294.18 million OptionableOptionable Beta1.56 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:HCAT) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Catalyst, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Catalyst With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.